Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrolamellar Liver Cancer”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Not applicableStudy completedNCT04874519
What this trial is testing

Registry to Collect Health Information Related to Fibrolamellar Cancer

Who this might be right for
Fibrolamellar CancerFLCLiver Cancer
Memorial Sloan Kettering Cancer Center 12
Not applicableUnknownNCT05681949
What this trial is testing

Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards

Who this might be right for
Hepatocellular CarcinomaFibrolamellar Hepatocellular CarcinomaCholangiocarcinoma, Perihilar+3 more
Charite University, Berlin, Germany 1,200
Not applicableWithdrawnNCT03748927
What this trial is testing

Natural History Study of Children and Adults With Fibrolamellar Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatocellular Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT04248569
What this trial is testing

DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

Who this might be right for
Fibrolamellar Hepatocellular Carcinoma (FLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 56
Testing effectiveness (Phase 2)Study completedNCT01642186
What this trial is testing

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

Who this might be right for
Fibrolamellar CarcinomaFibrolamellar Liver Cancer
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT01215565
What this trial is testing

Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma

Who this might be right for
Hepatocellular CarcinomaFibrolamellar Hepatocellular Carcinoma
Assistance Publique - Hôpitaux de Paris 4
Large-scale testing (Phase 3)Active Not RecruitingNCT03533582
What this trial is testing

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Who this might be right for
Childhood Hepatocellular CarcinomaChildhood Malignant Liver NeoplasmFibrolamellar Carcinoma+2 more
Children's Oncology Group 537
Testing effectiveness (Phase 2)Looking for participantsNCT04134559
What this trial is testing

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma, ChildhoodFibrolamellar CarcinomaLiver Cancer+1 more
Allison O'Neill, MD 18
Testing effectiveness (Phase 2)WithdrawnNCT02702960
What this trial is testing

Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)

Who this might be right for
Fibrolamellar Hepatocellular CarcinomaHepatocellular Carcinoma (Fibrolamellar Variant)Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Active Not RecruitingNCT03860272
What this trial is testing

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

Who this might be right for
Advanced CancerAngiosarcomaColorectal Cancer Without Liver Metastases+5 more
Agenus Inc. 499
Testing effectiveness (Phase 2)Temporarily pausedNCT05468359
What this trial is testing

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

Who this might be right for
Refractory Solid TumorHepatocellular CarcinomaMalignant Solid Tumor+3 more
St. Jude Children's Research Hospital 64
Not applicableLooking for participantsNCT06541652
What this trial is testing

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

Who this might be right for
HepatocholangiocarcinomaFibrolamellar CarcinomaHepatic Epithelioid Hemangioendothelioma+7 more
Federation Francophone de Cancerologie Digestive 150
Testing effectiveness (Phase 2)WithdrawnNCT04025567
What this trial is testing

Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral

Who this might be right for
Metastatic Hepatocellular CarcinomaHepatocellular Carcinoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT06521567
What this trial is testing

Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

Who this might be right for
MelanomaHodgkin LymphomaHigh and Low Grade Glioma+9 more
GlaxoSmithKline 83
Testing effectiveness (Phase 2)Temporarily pausedNCT05603572
What this trial is testing

KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular CarcinomaFibrolamellar Carcinoma
Primocure Pharma 148
Testing effectiveness (Phase 2)Looking for participantsNCT04380545
What this trial is testing

Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer

Who this might be right for
Stage III Hepatocellular Carcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8Stage IIIB Hepatocellular Carcinoma AJCC v8+4 more
M.D. Anderson Cancer Center 15
Not applicableUnknownNCT05730686
What this trial is testing

FibroLamellar Carcinoma: an International Registry Study

Who this might be right for
Fibrolamellar Cancer of the Liver
Imperial College London 200